Brinker Capital Investments’s Allergan plc AGN Stock Holding History

Brinker Capital Investments’s Portfolio AGN Stock Details AGN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q1	–	Sell	-77	Closed	-$15K	–	822
2019 Q4	$15K	Hold	77	–	–	﹤0.01%	537
2019 Q3	$13K	Buy	+77	New	+$12.5K	﹤0.01%	549
2017 Q2	–	Sell	-49	Closed	-$12K	–	526
2017 Q1	$12K	Hold	49	–	–	﹤0.01%	388
2016 Q4	$10K	Buy	49 +46	+1,533%	+$9.53K	﹤0.01%	398
2016 Q3	$1K	Buy	+3	New	+$733	﹤0.01%	478
2016 Q1	–	Sell	-8	Closed	-$3K	–	739
2015 Q4	$3K	Sell	8 -14	-64%	-$4.17K	﹤0.01%	459
2015 Q3	$6K	Sell	22 -1,194	-98%	-$367K	﹤0.01%	391
2015 Q2	$369K	Sell	1,216 -130	-10%	-$38.8K	0.01%	236
2015 Q1	$401K	Sell	1,346 -79	-6%	-$22.5K	0.02%	232
2014 Q4	$367K	Sell	1,425 -207	-13%	-$51.7K	0.01%	231
2014 Q3	$394K	Sell	1,632 -145	-8%	-$32.5K	0.02%	218
2014 Q2	$396K	Buy	+1,777	New	+$368K	0.01%	235

Other funds holding AGN

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Credit Suisse Zurich, Switzerland $104B AUM 34.76% 1-Year Est. Return

Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return

FCM

Farallon Capital Management San Francisco, California $17.5B AUM 50.95% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Citigroup New York $303B AUM 53.02% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Brinker Capital Investments's AGN Position: Q1 2020 in Review

Brinker Capital Investments sold out of Allergan plc (AGN) in Q1 2020, closing a stake of 77 shares — an estimated $15K sold.

Brinker Capital Investments first reported a position in AGN in Q2 2014 and held it in 12 quarters. The position peaked at $401K in Q1 2015. 876 funds tracked by Wall St. Rank hold AGN as of Q1 2020.

Brinker Capital Investments reported no remaining Allergan plc position as of Q1 2020 after selling out during the quarter.
Brinker Capital Investments sold 77 Allergan plc shares in Q1 2020, an estimated $15K.
Brinker Capital Investments first reported a position in Allergan plc in Q2 2014 and held it in 12 quarters.
Brinker Capital Investments's Allergan plc position peaked at $401K in Q1 2015.
876 funds tracked by Wall St. Rank held Allergan plc as of Q1 2020.

Based on Brinker Capital Investments's 13F filing for Q1 2020, filed 13 May 2020.